Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

AVXL

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$2.70
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals, Options

Key stats

Market Cap
$250.21M
P/E Ratio
-6.26
EPS
-0.54
Dividend Yield
Not covered
52W Position
3%
Beta
1.41

Valuation multiples

Fwd P/E
1.54
PEG
0.00
P/B
1.98
P/S
Not covered
EV/Revenue
Not covered
ROE
-31.5%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 3%
$2.41$13.99

Latest Financials

2025-09-30 FY
Revenue
–
Net Income
-$46.38M
Total Assets
$103.81M
Free Cash Flow
–

Recent news